Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

50%

Ph early_phase_1

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Early Phase 1First-in-human

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Other(2)

Detailed Status

Completed2

unknown2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Early Phase 1

Trials by Phase

Early Phase 11 (33.3%)

N/A2 (66.7%)

Trials by Status

completed250%

unknown250%

Recent Activity

0 active trials

Showing 4 of 4

completed

Rectal Cancer Staging Using Whole Body MR-PET

NCT02651701

unknownnot_applicable

Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction

NCT03053804

completednot_applicable

MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study

NCT02334371

unknownearly_phase_1

PET-CT vs. Integrated MR-PET Scanning of GYN Cancers

NCT01779128

Clinical Trials (4)

Showing 4 of 4 trials

NCT02651701

Rectal Cancer Staging Using Whole Body MR-PET

Completed

NCT03053804Not Applicable

Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction

Unknown

NCT02334371Not Applicable

MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study

Completed

NCT01779128Early Phase 1

PET-CT vs. Integrated MR-PET Scanning of GYN Cancers

Unknown

All 4 trials loaded

Drug Details

Intervention Type: RADIATION
Total Trials: 4